Figure 2B shows that samples #1 to #3 (non-malignant tumors) and healthy control hepatocytes all showed very low levels of cell surface receptor expression, whereas samples #4 to #14 (HCC tumors) showed significantly higher receptor expression levels compared to non-malignant tumors (p = 0.05 for integrin v/β3; p = 0.05 for p32; p = 0.05 for NRP-1). Here, CD177 is linked to hepatocellular carcinoma.